Degraded peptides deliver less active compound than expected, effectively reducing your dose despite correct volume measurement
GLP-1 medications, already used for treatment of obesity and type 2 diabetes, will expand into treatment for other chronic diseases such as heart health, kidney disease and addiction, according to the panel
Peptides for ApoB: Why diet and fasting outperform any peptide here, and where Cardiogen, BPC and Reta offer cardiovascular support Wolverine Stack for Old Chronic Injuries: Why TB-500 is the key compound for dormant injuries, how GHK-CU supports nerve healing, and why movement matters as much as the peptide Mixing Peptides in One Syringe: What to never combine, why AOD needs its own water, and when HGH and GLPs should always stay separate Endometriosis & Hashimoto's Protocol: Why KPV and TA-1 are right, the role of LL-37 at micro doses, and why VIP helps flush the Herxheimer reaction Peptides for Your Dog's Bad Hips: Why BPC and TB-500 work on canines, how to dose by weight, and why injecting right at the hips is the best approach Subscribe for weekly, no-fluff protocols, dosing guidance, and real-world results
OHearn A
